- Home
- ASMB vs DTSQ Comparison
ASMB vs DTSQ Comparison
Compare ASMB & DTSQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASMB
- DTSQ
- Stock Information
- Founded
- ASMB 2005
- DTSQ 2022
- Country
- ASMB United States
- DTSQ United States
- Employees
- ASMB N/A
- DTSQ N/A
- Industry
- ASMB Biotechnology: Pharmaceutical Preparations
- DTSQ
- Sector
- ASMB Health Care
- DTSQ
- Exchange
- ASMB Nasdaq
- DTSQ NYSE
- Market Cap
- ASMB 130.2M
- DTSQ 91.7M
- IPO Year
- ASMB 2010
- DTSQ 2024
- Fundamental
- Price
- ASMB $18.14
- DTSQ N/A
- Analyst Decision
- ASMB Strong Buy
- DTSQ
- Analyst Count
- ASMB 3
- DTSQ 0
- Target Price
- ASMB $33.00
- DTSQ N/A
- AVG Volume (30 Days)
- ASMB 41.3K
- DTSQ 353.0
- Earning Date
- ASMB 08-07-2025
- DTSQ 01-01-0001
- Dividend Yield
- ASMB N/A
- DTSQ N/A
- EPS Growth
- ASMB N/A
- DTSQ N/A
- EPS
- ASMB N/A
- DTSQ 0.28
- Revenue
- ASMB $32,154,000.00
- DTSQ N/A
- Revenue This Year
- ASMB $0.04
- DTSQ N/A
- Revenue Next Year
- ASMB N/A
- DTSQ N/A
- P/E Ratio
- ASMB N/A
- DTSQ $37.05
- Revenue Growth
- ASMB 148.33
- DTSQ N/A
- 52 Week Low
- ASMB $7.75
- DTSQ $9.96
- 52 Week High
- ASMB $19.93
- DTSQ $10.47
- Technical
- Relative Strength Index (RSI)
- ASMB 68.18
- DTSQ N/A
- Support Level
- ASMB $17.45
- DTSQ N/A
- Resistance Level
- ASMB $18.92
- DTSQ N/A
- Average True Range (ATR)
- ASMB 0.87
- DTSQ 0.00
- MACD
- ASMB -0.05
- DTSQ 0.00
- Stochastic Oscillator
- ASMB 74.68
- DTSQ 0.00
About ASMB Assembly Biosciences Inc.
Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.
About DTSQ DT CLOUD STAR ACQUISITION CORP
DT Cloud Star Acquisition Corp is a blank check company.